Search

everythinglearnresearchcommunity

for

Search:↓

PCOS increases the risk of heart disease and type 2 diabetes in women.

Hair follicle culture helps study hair growth but has limitations in modeling the full hair cycle.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

PCOS may have evolved as an advantage in past environments with food scarcity.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

PCOS is a common hormonal disorder in women, causing symptoms like acne and irregular periods, and is managed with medication and lifestyle changes.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.